Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XL7C
|
|||
| Former ID |
DNC005020
|
|||
| Drug Name |
4-Pyridin-2-yl-5-quinolin-4-yl-thiazol-2-ylamine
|
|||
| Synonyms |
CHEMBL181640; SCHEMBL410002; 4-Pyridin-2-yl-5-quinolin-4-yl-thiazol-2-ylamine; UPYLCJSMNYCTLZ-UHFFFAOYSA-N; BDBM50151348; 4-(pyridin-2-yl)-5-(quinolin-4-yl)thiazol-2-amine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C17H12N4S
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=CC=N2)C3=C(N=C(S3)N)C4=CC=CC=N4
|
|||
| InChI |
1S/C17H12N4S/c18-17-21-15(14-7-3-4-9-19-14)16(22-17)12-8-10-20-13-6-2-1-5-11(12)13/h1-10H,(H2,18,21)
|
|||
| InChIKey |
UPYLCJSMNYCTLZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors. J Med Chem. 2004 Aug 26;47(18):4494-506. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.